Publication & Citation Trends
Publications
14 total
Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice
Cited by 39
OpenAlex
Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts
Cited by 105
OpenAlex
Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.
Cited by 53
OpenAlex
Reduced antibody response to streptavidin through site‐directed mutagenesis PDF
Cited by 70
OpenAlex
Preclinical Evaluation of a Humanized NR-LU-10 Antibody-Streptavidin Fusion Protein for Pretargeted Cancer Therapy
Cited by 31
OpenAlex
Research Topics
Radiopharmaceutical Chemistry and Applications
(8)
Monoclonal and Polyclonal Antibodies Research
(6)
Glycosylation and Glycoproteins Research
(4)
Cell Adhesion Molecules Research
(3)
Carbohydrate Chemistry and Synthesis
(3)
Affiliations
Scripps Research Institute
National Institutes of Health
Nexen (Canada)
National Cancer Institute
IDEX Corporation (United States)